13th Aug 2024 10:16
Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Reports that Bassam Kanaan, executive vice president of corporate development and M&A, sold 35,000 shares at 1,960 pence each for GBP686,000 on Thursday. He subsequently sold 10,000 shares at 2,025p each for GBP202,500. Proceeds for the disposals total GBP888,500. Both transactions took place on the London Stock Exchange.
Current stock price: 1,998.55p, down 0.2% in London on Tuesday morning
12-month change: down 6.9%
By Emma Curzon, Alliance News reporter
Comments and questions to [email protected]
Copyright 2024 Alliance News Ltd. All Rights Reserved.